Health Ministry to amend 2019 rules for new drugs, clinical trials

Requirements for test licenses, and applications for studies on bioavailability, bioequivalence to be streamlined; regulatory reforms expected to benefit stakeholders by significantly reducing timelines for processing applications

​Requirements for test licenses, and applications for studies on bioavailability, bioequivalence to be streamlined; regulatory reforms expected to benefit stakeholders by significantly reducing timelines for processing applications